BBLG insider filings
Bone Biologics Corp — 32 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-30. Screen BBLG transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Angle Siddhesh Rajendra — Director | 1 | — | — | 1 |
| Gagnon Robert E. — Director | 1 | — | — | 1 |
| Meikle Phillip Terry II — Director | 1 | — | — | 1 |
| Stroever Bruce — Director | 1 | — | — | 1 |
Recent insider filings — Bone Biologics Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-30 | 4 | Gagnon Robert E. — Director | Grant/award (A): 113,896 (derivative) @ $0 | EDGAR |
| 2026-09-30 | 4 | Angle Siddhesh Rajendra — Director | Grant/award (A): 113,896 (derivative) @ $0 | EDGAR |
| 2026-09-30 | 4 | Meikle Phillip Terry II — Director | Grant/award (A): 113,896 (derivative) @ $0 | EDGAR |
| 2026-09-30 | 4 | Stroever Bruce — Director | Grant/award (A): 113,896 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Walsh Deina H — Chief Financial Officer | Grant/award (A): 8,335 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Frelick Jeff — Chief Executive Officer | Grant/award (A): 16,668 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Stroever Bruce — Director | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Meikle Phillip Terry II — Director | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Gagnon Robert E. — Director | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Angle Siddhesh Rajendra — Director | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-01-21 | 4 | Frelick Jeff — Chief Executive Officer | Grant/award (A): 54,110 (derivative) @ $0 | EDGAR |
| 2025-01-21 | 4 | Walsh Deina H — Chief Financial Officer | Grant/award (A): 27,055 (derivative) @ $0 | EDGAR |
| 2024-10-18 | 4 | Meikle Phillip Terry II — Director | Grant/award (A): 9 (derivative) @ $0 · Grant/award (A): 28,185 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | Stroever Bruce — Director | Grant/award (A): 30,713 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | Gagnon Robert E. — Director | Grant/award (A): 30,713 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | Angle Siddhesh Rajendra — Director | Grant/award (A): 30,713 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Walsh Deina H — Chief Financial Officer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Frelick Jeff — Chief Executive Officer | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | Gagnon Robert E. — Director | Grant/award (A): 9 (derivative) @ $0 · Grant/award (A): 8.01 (derivative) @ $0 | EDGAR |
| 2023-09-20 | 4 | Lucera Erick — Director | Grant/award (A): 85,763 (derivative) @ $0 | EDGAR |
| 2023-09-20 | 4 | Angle Siddhesh Rajendra — Director | Grant/award (A): 85,763 (derivative) @ $0 | EDGAR |
| 2023-09-20 | 4 | Stroever Bruce — Director | Grant/award (A): 85,763 (derivative) @ $0 | EDGAR |
| 2023-09-14 | 4 | Walsh Deina H — Chief Financial Officer | Purchase (P): 8,000 @ $0.64 | EDGAR |
| 2023-09-12 | 4 | Frelick Jeff — Chief Executive Officer | Purchase (P): 9,500 @ $0.69 | EDGAR |
| 2023-09-07 | 4 | Walsh Deina H — Chief Financial Officer | Purchase (P): 300 @ $0.70 · Purchase (P): 6,700 @ $0.71 | EDGAR |
| 2023-09-05 | 4 | Frelick Jeff — Chief Executive Officer | Purchase (P): 7,600 @ $0.66 | EDGAR |
| 2023-03-29 | 4 | Hankey Don — Chairman of the Board, Director, 10% owner Knight Insurance Company, Ltd — 10% owner | Other (J): 500,137 @ $0 · Other (J): 33,811 (derivative) @ $0.01 · Other (J): 280,764 (derivative) @ $0.01 · Other (J): 5,252 (derivative) @ $0.01 · Other (J): 99,148 (derivative) @ $0.01 · Other (J): 19,297 (derivative) @ $0.01 · +1 more | EDGAR |
| 2023-03-08 | 4 | Stroever Bruce — Director | Grant/award (A): 36,845 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Frelick Jeff — Chief Executive Officer | Grant/award (A): 37,750 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Angle Siddhesh Rajendra — Director | Grant/award (A): 36,845 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Lucera Erick — Director | Grant/award (A): 36,845 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Walsh Deina H — Chief Financial Officer | Grant/award (A): 18,875 (derivative) @ $0 | EDGAR |
Recent 8-K events — Bone Biologics Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-29 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-09-16 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-07-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-26 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BBLG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →